Skip to content

Effects of Transcranial Direct Current Stimulation (tDCS) on Persistent Auditory Verbal Hallucinations in Schizophrenia

The Neural, Behavioural, and Cognitive Outcomes of Transcranial Direct Current Stimulation (tDCS) for Persistent Auditory Verbal Hallucinations in Schizophrenia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04222582
Enrollment
84
Registered
2020-01-10
Start date
2019-01-01
Completion date
2021-01-31
Last updated
2020-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auditory Hallucination, Verbal

Keywords

Schizophrenia, Transcranial direct current stimulation (tDCS), Schizoaffective disorder, EEG, Brain imaging, Cognition

Brief summary

Many individuals with schizophrenia struggle with auditory verbal hallucinations (AVHs). In some cases, these AVHs can be resistant to medication treatment. Previous research has found that transcranial direct current stimulation (tDCS) can be helpful in treating symptoms in individuals with other psychiatric disorders, such as depression. This study will assess if tDCS is effective in treating AVHs in individuals with schizophrenia. tDCS is a non-invasive form of brain stimulation which uses a weak current to temporarily excite or inhibit underlying cortical regions with small electrodes placed on the scalp. tDCS has been found to improve mental processes, including attention and memory function. In addition to examining the effect of tDCS on AVHs, this study will assess the effects of tDCS on mood as well as brain electrical activity with electroencephalogram (EEG) recordings. As an additional component, participants will be invited to participate in neuroimaging. Using magnetic resonance imaging (MRI), brain activity and structure will be examined before and after tDCS. tDCS will be administered twice daily for 5 consecutive days for a total of 10 sessions. These study findings will contribute to the understanding of the impact of tDCS on AVHs, and will also increase knowledge of sound and memory/cognitive processing in individuals with schizophrenia.

Interventions

DEVICETranscranial direct current stimulation (tDCS)

Transcranial direct current stimulation (tDCS) is a non-invasive form of brain stimulation which uses a weak current (2mA direct current) to temporarily excite or inhibit underlying brain regions with small electrodes placed on the scalp.

Sponsors

The Royal Ottawa Mental Health Centre
CollaboratorOTHER
University of Ottawa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Patients - Inclusion Criteria: * Primary diagnosis of schizophrenia or schizoaffective disorder * Clinically stable (discretion of psychiatrist) * Consistent history of AVHs over the course of illness * \>3 AVHs per week * Positive and Negative Syndrome Scale (PANSS) score of \>3 * Primary medications limited to one of the atypical antipsychotics (medications stabilized for 4 weeks prior to enrollment) Patients -

Exclusion criteria

* Experiencing an acute psychotic episode * Current drug/alcohol dependence * Significant medical illness & mental retardation/learning disability * Extra-pyramidal symptoms resulting in disordered movement * Abnormal audiometric assessment (thresholds for pure tones \>25 dB) * History of significant neurological issues & head injuries/concussions resulting in loss of consciousness for \>5 minutes Healthy Controls - Inclusion Criteria: * In good physical health * No history of serious mental health issues Healthy Controls -

Design outcomes

Primary

MeasureTime frameDescription
Change in auditory hallucination severity measured by the Psychotic Symptom Rating Scale (PSYRATS)Baseline, after 2nd tDCS session on days 1, 3, and 5, and follow-up (within a week of completing tDCS)The PSYRATS is a multidimensional measure of auditory hallucinations, including 11 items rated on five-point (0-4) scales (total score range 0-44). Symptoms are rated over the last week, with higher scores reflecting more severe symptoms. The dimensions assessed are frequency, duration, location, loudness, beliefs about origin, negative content, intensity of negative content, amount of distress, intensity of distress, disruption of life and control.

Secondary

MeasureTime frameDescription
Change in Beliefs about Voices Questionnaire-Revised (BAVQ-R) Scores3 weeks (baseline to follow-up)The BAVQ-R is a 35-item questionnaire assessing people's beliefs about auditory hallucinations, and their emotional and behavioural reactions to them. All responses are rated on a 4-point scale: disagree (0); unsure (1); agree slightly (2); agree strongly (3), the measure thus assesses degree of endorsement of items. The scale consists of five subscales: malevolence (score range 0-18), benevolence (0-18), omnipotence (0-18), resistance (0-27), and engagement (0-24).
Change in Voices Acceptance and Action Scale (VAAS) Scores3 weeks (baseline to follow-up)The VAAS was developed to assess acceptance-based or action-based beliefs in response to auditory verbal hallucinations, in general and specifically to command hallucinations. This 31-item scale is divided into section A (i.e., 12 item stand-alone scale for general auditory hallucinations) and section B, referring specifically to command hallucinations. The participant is asked to rate their opinion from 1 'Strongly Disagree' to 5 'Strongly Agree', with higher scores meaning higher levels of acceptance and perception of acting according to one's valued life directions. Section A scores can range from 12-60, while section B scores can range from 19-95.
Change in Electroencephalography (EEG) - Resting-State Alpha Power3 weeks (baseline to follow-up)Changes in resting-state EEG power in alpha band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Resting-State Beta Power3 weeks (baseline to follow-up)Changes in resting-state EEG power in beta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Resting-State Delta Power3 weeks (baseline to follow-up)Changes in resting-state EEG power in delta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Resting-State Theta Power3 weeks (baseline to follow-up)Changes in resting-state EEG power in theta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Resting-State Gamma Power3 weeks (baseline to follow-up)Changes in resting-state EEG power in gamma band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Voice Power Differential Scale (VPDS) Scores3 weeks (baseline to follow-up)The Voice Power Differential Scale (VPDS) is a 7-item scale used to measure the perceived power differences between the voice and the voice hearer. Each item is rated on a five-point scale (1-5), with higher scores indicating greater power differential in favour of the voices, with total scores ranging from 7-35.
Change in Electroencephalography (EEG) - P503 weeks (baseline to follow-up)Change in T/C ratio (testing stimulus/conditioning stimulus) during paired click test. Change in T/C difference (testing stimulus - conditioning stimulus) during paired click test
Change in Brain Functional Magnetic Resonance Imaging (fMRI) - Resting-State3 weeks (baseline to follow-up)Changes in resting-state activity and connectivity within and between the auditory cortex and select regions of the default-mode network.
Change in Brain Functional Magnetic Resonance Imaging (fMRI) - Mismatch Negativity (tonal)3 weeks (baseline to follow-up)Changes in task-related activity and connectivity within and between the auditory cortex and select regions of the default-mode network .
Change in Brain Magnetic Resonance Spectroscopy (MRS)3 weeks (baseline to follow-up)Changes in glutamate/glutamine (Glu/Gln) concentrations in the auditory cortex.
Change in Cambridge Neuropsychological Test Automated Battery (CANTAB) Schizophrenia Battery3 weeks (baseline to follow-up)Changes in cognitive functioning abilities in core domains often affected in psychosis.
Change in Social Cognition - Social Attribution Task3 weeks (baseline to follow-up)Changes in social cognition/social inference abilities measured by a computerized social attribution task.
Change in Electroencephalography (EEG) - Mismatch Negativity (MMN)3 weeks (baseline to follow-up)Change in MMN peak amplitudes and latencies to non-speech (tonal) deviants and speech (syllabic) deviants during the multi-feature optimal MMN paradigm.

Countries

Canada

Contacts

Primary ContactBronwen Schryver, B.Sc.
bronwen.schryver@theroyal.ca613 722 6521

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026